IBDEI035 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1021,0)
 ;;=F43.10^^6^109^1
 ;;^UTILITY(U,$J,358.3,1021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1021,1,3,0)
 ;;=3^PTSD Unspec
 ;;^UTILITY(U,$J,358.3,1021,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,1021,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,1022,0)
 ;;=F43.12^^6^109^2
 ;;^UTILITY(U,$J,358.3,1022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1022,1,3,0)
 ;;=3^PTSD,Chr
 ;;^UTILITY(U,$J,358.3,1022,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,1022,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,1023,0)
 ;;=G20.^^6^109^19
 ;;^UTILITY(U,$J,358.3,1023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1023,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,1023,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,1023,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,1024,0)
 ;;=I73.9^^6^109^3
 ;;^UTILITY(U,$J,358.3,1024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1024,1,3,0)
 ;;=3^PVD,Unspecified
 ;;^UTILITY(U,$J,358.3,1024,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,1024,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,1025,0)
 ;;=I80.3^^6^109^28
 ;;^UTILITY(U,$J,358.3,1025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1025,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis Lower Extremities,Unspec
 ;;^UTILITY(U,$J,358.3,1025,1,4,0)
 ;;=4^I80.3
 ;;^UTILITY(U,$J,358.3,1025,2)
 ;;=^5007845
 ;;^UTILITY(U,$J,358.3,1026,0)
 ;;=J02.9^^6^109^24
 ;;^UTILITY(U,$J,358.3,1026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1026,1,3,0)
 ;;=3^Pharyngitis Acute,Unspec
 ;;^UTILITY(U,$J,358.3,1026,1,4,0)
 ;;=4^J02.9
 ;;^UTILITY(U,$J,358.3,1026,2)
 ;;=^5008130
 ;;^UTILITY(U,$J,358.3,1027,0)
 ;;=J18.9^^6^109^31
 ;;^UTILITY(U,$J,358.3,1027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1027,1,3,0)
 ;;=3^Pneumonia,Unspec Organism
 ;;^UTILITY(U,$J,358.3,1027,1,4,0)
 ;;=4^J18.9
 ;;^UTILITY(U,$J,358.3,1027,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,1028,0)
 ;;=R09.1^^6^109^30
 ;;^UTILITY(U,$J,358.3,1028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1028,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,1028,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,1028,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,1029,0)
 ;;=J91.8^^6^109^29
 ;;^UTILITY(U,$J,358.3,1029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1029,1,3,0)
 ;;=3^Pleural Effusion in Conditions Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,1029,1,4,0)
 ;;=4^J91.8
 ;;^UTILITY(U,$J,358.3,1029,2)
 ;;=^5008311
 ;;^UTILITY(U,$J,358.3,1030,0)
 ;;=K85.9^^6^109^18
 ;;^UTILITY(U,$J,358.3,1030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1030,1,3,0)
 ;;=3^Pancreatitis Acute,Unspec
 ;;^UTILITY(U,$J,358.3,1030,1,4,0)
 ;;=4^K85.9
 ;;^UTILITY(U,$J,358.3,1030,2)
 ;;=^5008887
 ;;^UTILITY(U,$J,358.3,1031,0)
 ;;=L40.0^^6^109^39
 ;;^UTILITY(U,$J,358.3,1031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1031,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,1031,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,1031,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,1032,0)
 ;;=L40.1^^6^109^41
 ;;^UTILITY(U,$J,358.3,1032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1032,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,1032,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,1032,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,1033,0)
 ;;=L40.3^^6^109^42
 ;;^UTILITY(U,$J,358.3,1033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1033,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,1033,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,1033,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,1034,0)
 ;;=L40.4^^6^109^38
 ;;^UTILITY(U,$J,358.3,1034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1034,1,3,0)
 ;;=3^Psoriasis Guttate
 ;;^UTILITY(U,$J,358.3,1034,1,4,0)
 ;;=4^L40.4
